Private Trust Co. NA Sells 144 Shares of The Clorox Company (NYSE:CLX)

Private Trust Co. NA cut its position in The Clorox Company (NYSE:CLX) by 5.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,362 shares of the company’s stock after selling 144 shares during the quarter. Private Trust Co. NA’s holdings in Clorox were worth $385,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new position in shares of Clorox in the third quarter valued at about $27,000. Innealta Capital LLC acquired a new position in shares of Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC increased its holdings in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the period. Family Firm Inc. acquired a new stake in shares of Clorox in the second quarter valued at approximately $31,000. Finally, Quarry LP boosted its stake in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.57% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on CLX shares. Deutsche Bank Aktiengesellschaft raised their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. BNP Paribas raised Clorox to a “strong sell” rating in a research note on Friday, September 6th. Barclays upped their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Finally, Citigroup increased their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $155.00.

Clorox Trading Down 0.1 %

Shares of CLX stock opened at $167.16 on Thursday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.69 billion, a P/E ratio of 58.24, a P/E/G ratio of 3.07 and a beta of 0.41. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.35. The stock’s fifty day simple moving average is $162.91 and its 200 day simple moving average is $149.01.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the business earned $0.49 EPS. The firm’s quarterly revenue was up 27.0% on a year-over-year basis. As a group, sell-side analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 2.92%. Clorox’s dividend payout ratio is 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.